Wave Financial Statements From 2010 to 2026

WVE Stock  USD 14.83  0.60  3.89%   
Wave Life's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Wave Life's valuation are provided below:
Gross Profit
-65.4 M
Profit Margin
(1.12)
Market Capitalization
2.6 B
Enterprise Value Revenue
21.9214
Revenue
109.2 M
There are over one hundred nineteen available fundamental gauges for Wave Life Sciences, which can be analyzed over time and compared to other ratios. Investors should ensure to confirm all of Wave Life's prevalent performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. The current year's Market Cap is expected to grow to about 1.6 B. The current year's Enterprise Value is expected to grow to about 1.4 B

Wave Life Total Revenue

130.77 Million

Check Wave Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Wave Life's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.8 M, Interest Expense of 1.8 M or Selling General Administrative of 36.3 M, as well as many indicators such as Price To Sales Ratio of 17.25, Dividend Yield of 0.0 or PTB Ratio of 8.92. Wave financial statements analysis is a perfect complement when working with Wave Life Valuation or Volatility modules.
  
Build AI portfolio with Wave Stock
Check out the analysis of Wave Life Correlation against competitors.

Wave Life Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets216.1 M405 M175.6 M
Slightly volatile
Short and Long Term Debt Total21.1 M29.2 M17 M
Slightly volatile
Other Current Liabilities25.5 M24.2 M10.5 M
Slightly volatile
Total Current Liabilities77.8 M127.6 M63.8 M
Slightly volatile
Other Liabilities96.6 M92 M42.6 M
Slightly volatile
Property Plant And Equipment Net30.2 M32.2 M23.3 M
Slightly volatile
Current Deferred Revenue52.5 M75.9 M41.3 M
Slightly volatile
Accounts Payable9.6 M18.7 M7.9 M
Slightly volatile
Cash364.8 M347.4 M142.2 M
Slightly volatile
Non Current Assets Total41.8 M36.6 M31.7 M
Slightly volatile
Other Assets4.1 M4.3 MM
Pretty Stable
Cash And Short Term Investments364.8 M347.4 M142.2 M
Slightly volatile
Common Stock Total Equity969.4 M923.3 M434.3 M
Slightly volatile
Common Stock Shares Outstanding167 M159 M53.5 M
Slightly volatile
Liabilities And Stockholders Equity216.1 M405 M175.6 M
Slightly volatile
Non Current Liabilities Total56.3 M36.5 M41.6 M
Slightly volatile
Other Current Assets10.6 M19.4 M8.6 M
Slightly volatile
Total Liabilities134.1 M164.1 M105.4 M
Slightly volatile
Property Plant And Equipment Gross89.7 M85.5 M35.2 M
Slightly volatile
Preferred Stock Total Equity7.4 M9.1 M6.5 M
Slightly volatile
Total Current Assets386.9 M368.5 M156.4 M
Slightly volatile
Short Term Debt9.2 M8.8 M5.4 M
Very volatile
Common Stock1.4 B1.4 B515.6 M
Slightly volatile
Property Plant Equipment22.5 M19.9 M16.8 M
Slightly volatile
Other Stockholder Equity188.9 M179.9 M62.6 M
Slightly volatile
Short and Long Term Debt13.7 K14.4 K40.2 K
Slightly volatile
Warrants6.3 M7.1 M7.7 M
Slightly volatile
Non Currrent Assets Other3.4 M4.4 M2.6 M
Slightly volatile
Long Term Debt Total13.7 K14.4 K37.7 K
Slightly volatile
Capital Surpluse144.2 M137.4 M55.6 M
Slightly volatile
Capital Lease Obligations22.1 M29.2 M14.9 M
Slightly volatile
Non Current Liabilities Other135.3 M128.9 M45.8 M
Slightly volatile
Deferred Long Term Asset Charges413.6 K644 K426.4 K
Slightly volatile
Net Working Capital252.9 M240.9 M127.8 M
Pretty Stable
Long Term Investments40 M45 M49.1 M
Slightly volatile
Capital Stock828.5 M1.4 B614.9 M
Slightly volatile

Wave Life Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization5.8 M10 M4.7 M
Slightly volatile
Selling General Administrative36.3 M67.9 M29.7 M
Slightly volatile
Other Operating Expenses137.3 M251.5 M111.6 M
Slightly volatile
Research Development101 M183.6 M81.9 M
Slightly volatile
Cost Of Revenue9.5 M10 M42.3 M
Pretty Stable
Total Operating Expenses264.1 M251.5 M101 M
Slightly volatile
Interest Income2.2 M1.8 M1.3 M
Slightly volatile
Non Operating Income Net Other1.7 M1.8 M1.9 M
Slightly volatile
Reconciled Depreciation8.9 M10 M5.8 M
Slightly volatile
Selling And Marketing Expenses7.4 M8.3 MM
Slightly volatile

Wave Life Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow130.8 M234.7 M105.5 M
Slightly volatile
Depreciation6.1 M10 M4.9 M
Slightly volatile
Capital Expenditures802 K844.2 K2.8 M
Very volatile
Total Cash From Financing Activities306.6 M292 M106.6 M
Slightly volatile
End Period Cash Flow369.3 M351.7 M144.2 M
Slightly volatile
Sale Purchase Of Stock91.9 M76 M63.2 M
Slightly volatile
Stock Based Compensation12.9 M15.1 M9.2 M
Slightly volatile
Change To Netincome13.5 M19.8 M10.5 M
Slightly volatile
Issuance Of Capital Stock285.2 M271.6 M111 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio17.2518.16856
Slightly volatile
Days Sales Outstanding5.245.51133
Very volatile
Stock Based Compensation To Revenue0.130.1410.3139
Slightly volatile
Capex To Depreciation0.120.10831.4573
Pretty Stable
EV To Sales14.4615.22471
Slightly volatile
Inventory Turnover16.313.6914.8424
Slightly volatile
Days Of Inventory On Hand20.327.625.215
Slightly volatile
Payables Turnover13.4310.3513.8833
Slightly volatile
Sales General And Administrative To Revenue0.60.6326.6715
Slightly volatile
Research And Ddevelopement To Revenue1.611.727.8761
Slightly volatile
Capex To Revenue0.00950.014.9163
Slightly volatile
Cash Per Share3.932.512.9185
Pretty Stable
Days Payables Outstanding44.346.64304
Very volatile
Income Quality1.471.40.9035
Pretty Stable
Current Ratio3.153.324.9409
Very volatile
Receivables Turnover71.9768.5515.6085
Slightly volatile
Capex Per Share0.00740.00780.0987
Very volatile
Revenue Per Share0.740.70.3445
Slightly volatile
Interest Debt Per Share0.20.210.8816
Slightly volatile
Debt To Assets0.07880.08291.033
Slightly volatile
Operating Cycle4.14.31114
Very volatile
Days Of Payables Outstanding44.346.64304
Very volatile
Ebt Per Ebit1.061.010.9763
Slightly volatile
Long Term Debt To Capitalization0.05340.10.0653
Slightly volatile
Quick Ratio3.153.324.9199
Very volatile
Net Income Per E B T0.790.890.9562
Very volatile
Cash Ratio2.973.134.7536
Very volatile
Days Of Inventory Outstanding20.327.625.215
Slightly volatile
Days Of Sales Outstanding5.245.51133
Very volatile
Free Cash Flow Operating Cash Flow Ratio1.211.161.0972
Pretty Stable
Fixed Asset Turnover3.663.481.0001
Slightly volatile
Debt Ratio0.07880.08291.033
Slightly volatile
Price Sales Ratio17.2518.16856
Slightly volatile
Asset Turnover0.290.280.1014
Slightly volatile

Wave Life Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.6 B1.5 B675.8 M
Slightly volatile
Enterprise Value1.4 B1.3 B503.2 M
Slightly volatile

Wave Fundamental Market Drivers

Wave Upcoming Events

27th of March 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Wave Life Financial Statements

Wave Life stakeholders use historical fundamental indicators, such as Wave Life's revenue or net income, to determine how well the company is positioned to perform in the future. Although Wave Life investors may analyze each financial statement separately, they are all interrelated. For example, changes in Wave Life's assets and liabilities are reflected in the revenues and expenses on Wave Life's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Wave Life Sciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue75.9 M52.5 M
Cost Of Revenue10 M9.5 M
Total Revenue124.5 M130.8 M
Stock Based Compensation To Revenue 0.14  0.13 
Sales General And Administrative To Revenue 0.63  0.60 
Research And Ddevelopement To Revenue 1.70  1.61 
Capex To Revenue 0.01  0.01 
Revenue Per Share 0.70  0.74 
Ebit Per Revenue(0.92)(0.96)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Wave Life Sciences is a strong investment it is important to analyze Wave Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Wave Life's future performance. For an informed investment choice regarding Wave Stock, refer to the following important reports:
Check out the analysis of Wave Life Correlation against competitors.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Wave Life. If investors know Wave will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Wave Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.65)
Revenue Per Share
0.666
Quarterly Revenue Growth
(0.56)
Return On Assets
(0.28)
Return On Equity
(0.87)
The market value of Wave Life Sciences is measured differently than its book value, which is the value of Wave that is recorded on the company's balance sheet. Investors also form their own opinion of Wave Life's value that differs from its market value or its book value, called intrinsic value, which is Wave Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Wave Life's market value can be influenced by many factors that don't directly affect Wave Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Wave Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Wave Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Wave Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.